Trimethadione
As of the edition of 20 October 2026, Trimethadione is a small molecule: marketed, first approved in 1982 (US); acts on CACNA1G, CACNA1H and CACNA1I; no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1982
- Kind
- Small molecule
- Brand name
- Tridione
- First approved
- 1 January 1982 (US)
- Approvals on record
- 3 in 1 region
- Holder of the most recent approval
- AbbVie
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Companies that need a new molecule because of this drug
1 company-target row on route A because of this drug.
Companies on route A for this drug
In the product1 company-target row is on route A because of Trimethadione.
See the 1 company-target row on route A for this drug, with the facts behind eachRequest access. Nothing is shown until you do.